Postoperative intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer trial
- Conditions
- Diseases of The genitoruinary system
- Registration Number
- KCT0004702
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 84
) histologicall confirmed cervical cancer
2) radical hysterectomy and pelvic lymph node dissection was done
3) indicated as below in pathology (more than one)
- pelvic lymph node metastasis
- parametrial involvement
- resection margin positive
4) age 20-70
5) ECOG 0-1
6) granulocyte =1.0 x 103/µl, platelet =30 x 103/µl, hemoglobin =10 g/dl
7) creatinine <2.0 mg/dL, bilirubin 1.5 mg/dl
8) If the patient voluntarily completes the consent form
1) distant metastiss (retroperitoneal lymph node metastasis)
2) previous pelvic radiohterapy
3) more than 3 months after radical hysterectomy
4) serious acute illness
5) neoadjuvant chemotherapy
6) radiotherapy alone patient
7) other cancer history except for thyroid cancer, skin cancer, cervix is situ
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method more than acute grade 3 toxicities
- Secondary Outcome Measures
Name Time Method more than chronic grade 3 toxicities